Experimental and Molecular Medicine

Papers
(The H4-Index of Experimental and Molecular Medicine is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The health effects of ultrafine particles427
Glutamine reliance in cell metabolism374
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity296
Single-cell multiomics: technologies and data analysis methods279
Ultrafine particles: unique physicochemical properties relevant to health and disease252
The emerging role of RNA modifications in the regulation of mRNA stability251
The mechanism of HMGB1 secretion and release218
Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development207
Type I and III interferon responses in SARS-CoV-2 infection180
On the origin and evolution of SARS-CoV-2170
Zebrafish as an animal model for biomedical research159
Autophagy as a decisive process for cell death153
Hepatocellular carcinoma: old friends and new tricks149
The effects of different dietary fiber pectin structures on the gastrointestinal immune barrier: impact via gut microbiota and direct effects on immune cells142
Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury141
Mechanisms of ultrafine particle-induced respiratory health effects140
The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies136
Single-cell sequencing techniques from individual to multiomics analyses128
Innate immune sensing of coronavirus and viral evasion strategies128
Stress and the dopaminergic reward system124
Optimization of primer sets and detection protocols for SARS-CoV-2 of coronavirus disease 2019 (COVID-19) using PCR and real-time PCR120
The force awakens: metastatic dormant cancer cells114
The aftermath of the interplay between the endoplasmic reticulum stress response and redox signaling111
Antibiotic resistome from the One-Health perspective: understanding and controlling antimicrobial resistance transmission110
Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms108
Single-cell transcriptomics in cancer: computational challenges and opportunities104
The M-CSF receptor in osteoclasts and beyond103
Targeting focal adhesion kinase in cancer cells and the tumor microenvironment101
Protein arginine methyltransferases: promising targets for cancer therapy100
Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children99
Tailoring photosensitive ROS for advanced photodynamic therapy97
Live biotherapeutic products: the importance of a defined regulatory framework92
Function of γδ T cells in tumor immunology and their application to cancer therapy91
Necroptosis molecular mechanisms: Recent findings regarding novel necroptosis regulators90
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance90
Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer90
Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis89
Lactobacillus paracasei-derived extracellular vesicles attenuate the intestinal inflammatory response by augmenting the endoplasmic reticulum stress pathway86
Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics84
The evolution and future of influenza pandemic preparedness84
Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis81
The role of selenium metabolism and selenoproteins in cartilage homeostasis and arthropathies78
LSD1: more than demethylation of histone lysine residues77
Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy76
Heterochromatin: an epigenetic point of view in aging76
Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions75
METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner73
Single-cell network biology for resolving cellular heterogeneity in human diseases72
β-hydroxybutyrate and its metabolic effects on age-associated pathology71
DNA end resection and its role in DNA replication and DSB repair choice in mammalian cells69
Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats69
Small but mighty: the causes and consequences of micronucleus rupture69
Insulin receptor endocytosis in the pathophysiology of insulin resistance68
Therapeutics targeting the fibrinolytic system68
Bystander CD4+ T cells: crossroads between innate and adaptive immunity68
Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway66
New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease56
0.077136993408203